Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000171

EVP, Chf GL Pdt Str Ofcr sold 4,902 shares at $75.17 ($368,488)

  • EVP, Chf GL Pdt Str Ofcr acquired 12,226 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Jenne Kyle EVP, Chf GL Pdt Str Ofcr 2026-04-15 Option exercise +12,226 28,615 D
Jenne Kyle EVP, Chf GL Pdt Str Ofcr 2026-04-16 Sale −4,902 $75.17 $368,488 23,713 D
Derivatives
Jenne Kyle EVP, Chf GL Pdt Str Ofcr 2026-04-15 Option exercise · Restricted Stock Unit −12,226 74,402 D
Open-market sales · 4,902 sh · avg $75.17 · $368,488
Loading xslF345X06/edgardoc.xml…